{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:23:19Z","timestamp":1793380999092,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"am","delay-in-days":265,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajem.2021.02.015","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T08:00:04Z","timestamp":1613548804000},"page":"157-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management"],"prefix":"10.1016","volume":"44","author":[{"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.02.015_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crisis in adults with diabetes","volume":"32","author":"Kitabachi","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2021.02.015_bb0010","first-page":"S72","article-title":"Hyperglycemic emergencies in adults","volume":"37","author":"Canadian Diabetes Association Clinical Practice Guidelines Expert Committee","year":"2013","journal-title":"Can J Diabetes"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jemermed.2020.06.059","article-title":"Evaluation and Management of the Critically ill Adult with Diabetic Ketoacidosis","volume":"59","author":"Long","year":"2020","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2021.02.015_bb0020","series-title":"NCHS National Hospital Discharge Survey","author":"Centers for Disease Control and Prevention","year":"2010"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1573399812666160421121307","article-title":"Euglycemic diabetic ketoacidosis: a review","volume":"13","author":"Modi","year":"2017","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.ajem.2021.02.015_bb0030","article-title":"Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma","volume":"2017","author":"Rawla","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"7","key":"10.1016\/j.ajem.2021.02.015_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11892-020-01307-x","article-title":"Euglycemic Ketoacidosis","volume":"20","author":"Bonora","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajem.2021.02.015_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","article-title":"Euglycaemic diabetic ketoacidosis","volume":"2","author":"Munro","year":"1973","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ajem.2021.02.015_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF00569937","article-title":"Euglycaemic diabetic ketoacidosis: does it exist?","volume":"30","author":"Jenkins","year":"1993","journal-title":"Acta Diabetol"},{"issue":"6","key":"10.1016\/j.ajem.2021.02.015_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"},{"issue":"25","key":"10.1016\/j.ajem.2021.02.015_bb0055","doi-asserted-by":"crossref","first-page":"E766","DOI":"10.1503\/cmaj.171319","article-title":"Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor","volume":"190","author":"Zhang","year":"2018","journal-title":"CMAJ."},{"issue":"9","key":"10.1016\/j.ajem.2021.02.015_bb0060","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12245-019-0240-0","article-title":"Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature","volume":"12","author":"Diaz-Ramos","year":"2019","journal-title":"Int J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2021.02.015_bb0070","first-page":"722","article-title":"Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor","volume":"62","author":"Jazi","year":"2016","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ajem.2021.02.015_bb0075","series-title":"Drugs and health products","author":"Health Canada [website]","year":"2016"},{"issue":"10166","key":"10.1016\/j.ajem.2021.02.015_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.ajem.2021.02.015_bb0085","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/dom.14075","article-title":"Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Liu","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.ajem.2021.02.015_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2924","article-title":"Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data","volume":"33","author":"Blau","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ajem.2021.02.015_bb0095","doi-asserted-by":"crossref","first-page":"7074868","DOI":"10.1155\/2018\/7074868","article-title":"Newer perspectives of mechanisms for Euglycemic diabetic ketoacidosis","volume":"2018","author":"Yu","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"12","key":"10.1016\/j.ajem.2021.02.015_bb0100","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.clinthera.2016.11.002","article-title":"SGLT2 inhibitor-associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis","volume":"38","author":"Goldenberg","year":"2016","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11606-008-0829-0","article-title":"Starvation-induced true diabetic euglycemic ketoacidosis in severe depression","volume":"24","author":"Joseph","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.02.015_bb0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/meta.2001.20194","article-title":"Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis","volume":"50","author":"Burge","year":"2001","journal-title":"Metabolism."},{"key":"10.1016\/j.ajem.2021.02.015_bb0115","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc15-1730","article-title":"Efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 inhibitor, as add-on to insulin in patients with type 1 diabetes","volume":"38","author":"Henry","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2021.02.015_bb0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc13-2955","article-title":"Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study","volume":"38","author":"Henry","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2021.02.015_bb0125","author":"Drug safety announcement"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s12020-017-1264-y","article-title":"Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology","volume":"56","author":"Pf\u00fctzner","year":"2017","journal-title":"Endocrine."},{"issue":"5","key":"10.1016\/j.ajem.2021.02.015_bb0140","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.02.015_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ajem.2021.02.015_bb0150","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1210\/jc.2015-1884","article-title":"SGLT2 inhibitors may predispose to ketoacidosis","volume":"100","author":"Simeon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ajem.2021.02.015_bb0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose Cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.ajem.2021.02.015_bb0160","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1210\/jc.2015-1884","article-title":"SGLT2 inhibitors may predispose to ketoacidosis","volume":"100","author":"Taylor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0165","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1447-0756.2008.00720.x","article-title":"Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy","volume":"34","author":"Guo","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"issue":"9\u201310","key":"10.1016\/j.ajem.2021.02.015_bb0170","first-page":"452","article-title":"Diabetic ketoacidosis occurring with lower blood glucose levels in pregnancy: a report of two cases","volume":"57","author":"Madaan","year":"2012","journal-title":"J Reprod Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11695-018-3548-6","article-title":"Normal blood glucose and high blood ketones in a critically unwell patient with T1DM post-bariatric surgery: a case of Euglycemic diabetic ketoacidosis","volume":"29","author":"Dowsett","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.ajem.2021.02.015_bb0180","first-page":"8769714","article-title":"Euglycemic diabetic ketoacidosis in pregnancy: a case report and review of current literature","volume":"2019","author":"Jaber","year":"2019","journal-title":"Case Rep Crit Care"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0185","first-page":"26","article-title":"Euglycemic diabetic ketoacidosis in pregnancy","volume":"4","author":"de Alencar","year":"2019","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"5","key":"10.1016\/j.ajem.2021.02.015_bb0190","first-page":"62","article-title":"Euglycemic diabetic ketoacidosis due to Gastroparesis, a local experience","volume":"112","author":"Legaspi","year":"2015","journal-title":"J Ark Med Soc"},{"issue":"6","key":"10.1016\/j.ajem.2021.02.015_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/M20-0289","article-title":"Sodium-glucose Cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study","volume":"173","author":"Douros","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajem.2021.02.015_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcjd.2017.05.004","article-title":"Insights into the recognition and management of SGLT2-inhibitor-associated ketoacidosis: it\u2019s not just euglycemic diabetic ketoacidosis","volume":"41","author":"Dizon","year":"2017","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.ajem.2021.02.015_bb0205","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00125-017-4301-8","article-title":"SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA adverse event reporting system","volume":"60","author":"Fadini","year":"2017","journal-title":"Diabetologia."},{"key":"10.1016\/j.ajem.2021.02.015_bb0210","first-page":"55","article-title":"Too much of a good thing. Management of diabetic ketoacidosis in adults","volume":"58","author":"Blouin","year":"2012","journal-title":"Can Fam Physician"},{"issue":"4","key":"10.1016\/j.ajem.2021.02.015_bb0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1900\/RDS.2016.13.217","article-title":"Blood ketones: measurement, interpretation, limitations, and utility in the Management of Diabetic Ketoacidosis","volume":"13","author":"Dhatariya","year":"2016","journal-title":"Rev Diabet Stud"},{"issue":"4","key":"10.1016\/j.ajem.2021.02.015_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/dc07-1683","article-title":"Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?","volume":"31","author":"Sheikh-Ali","year":"2008","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ajem.2021.02.015_bb0225","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/dc10-1844","article-title":"Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: {beta}-hydroxybutyrate versus the urine dipstick","volume":"34","author":"Arora","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2021.02.015_bb0230","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.12659\/AJCR.917226","article-title":"Starvation ketoacidosis due to the Ketogenic diet and prolonged fasting - a possibly dangerous diet trend","volume":"20","author":"Blanco","year":"2019","journal-title":"Am J Case Rep"},{"issue":"2","key":"10.1016\/j.ajem.2021.02.015_bb0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/jcrc.2000.7900","article-title":"Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis","volume":"15","author":"Umpierrez","year":"2000","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.ajem.2021.02.015_bb0240","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/emj.2004.017590","article-title":"Alcoholic ketoacidosis","volume":"23","author":"McGuire","year":"2006","journal-title":"Emerg Med J"},{"issue":"15","key":"10.1016\/j.ajem.2021.02.015_bb0245","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.1989.03430150076029","article-title":"Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit","volume":"262","author":"Adrogue","year":"1989","journal-title":"Jama."},{"issue":"5","key":"10.1016\/j.ajem.2021.02.015_bb0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-96-5-570","article-title":"Relation of colloid osmotic pressure to arterial hypoxemia and cerebral edema during crystalloid volume loading of patients with diabetic ketoacidosis","volume":"96","author":"Fein","year":"1982","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.02.015_bb0255","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/qjmed\/hcr226","article-title":"Fluid management in diabetic-acidosis--Ringer\u2019s lactate versus normal saline: a randomized controlled trial","volume":"105","author":"Van Zyl","year":"2012","journal-title":"Qjm."},{"issue":"6","key":"10.1016\/j.ajem.2021.02.015_bb0260","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ajem.2010.02.004","article-title":"Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis","volume":"29","author":"Mahler","year":"2011","journal-title":"Am J Emerg Med"},{"issue":"2","key":"10.1016\/j.ajem.2021.02.015_bb0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcrc.2012.01.007","article-title":"Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis","volume":"27","author":"Chua","year":"2012","journal-title":"J Crit Care"},{"issue":"11","key":"10.1016\/j.ajem.2021.02.015_bb0270","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24596","article-title":"Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials","volume":"3","author":"Self","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0275","doi-asserted-by":"crossref","first-page":"786","DOI":"10.12669\/pjms.323.9201","article-title":"Euglycemic diabetic ketoacidosis in a 27 year-old female patient with type-1-diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin","volume":"32","author":"Bader","year":"2016","journal-title":"Pak J Med Sci"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.mcna.2016.12.011","article-title":"Management of Hyperglycemic Crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"101","author":"Fayfman","year":"2017","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.ajem.2021.02.015_bb0285","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jemermed.2013.03.040","article-title":"Hyperglycemic crisis","volume":"45","author":"Van Ness-Otunnu","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2021.02.015_bb0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.metabol.2016.11.010","article-title":"Controversies in the management of hyperglycaemic emergencies in adults with diabetes","volume":"68","author":"Cardoso","year":"2017","journal-title":"Metabolism."},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2021.02.015_bb0295","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jcjd.2013.01.023","article-title":"Hyperglycemic emergencies in adults","volume":"37","author":"Goguen","year":"2013","journal-title":"Can J Diabetes"},{"issue":"5","key":"10.1016\/j.ajem.2021.02.015_bb0300","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11892-017-0857-4","article-title":"Treatment of diabetic ketoacidosis (DKA)\/hyperglycemic hyperosmolar state (HHS): novel advances in the Management of Hyperglycemic Crises (UK versus USA)","volume":"17","author":"Dhatariya","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajem.2021.02.015_bb0305","author":"Joint British Diabetes Societies Inpatient Care Group"},{"issue":"2","key":"10.1016\/j.ajem.2021.02.015_bb0310","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0002-9343(83)91203-2","article-title":"Sodium bicarbonate therapy in severe diabetic ketoacidosis","volume":"75","author":"Lever","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0196-0644(98)70279-3","article-title":"Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis","volume":"31","author":"Green","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"11","key":"10.1016\/j.ajem.2021.02.015_bb0320","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2337\/diacare.25.11.2113","article-title":"The use of alkali therapy in severe diabetic ketoacidosis","volume":"25","author":"Latif","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ajem.2021.02.015_bb0325","first-page":"234","article-title":"Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial","volume":"43","author":"Gamba","year":"1991","journal-title":"Rev Investig Clin"},{"issue":"7779","key":"10.1016\/j.ajem.2021.02.015_bb0330","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(72)92083-1","article-title":"Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate","volume":"2","author":"Soler","year":"1972","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.ajem.2021.02.015_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2110-5820-1-23","article-title":"Bicarbonate in diabetic ketoacidosis - a systematic review","volume":"1","author":"Chua","year":"2011","journal-title":"Ann Intensive Care"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:53:59Z","timestamp":1760025239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":66,"alternative-id":["S0735675721001212"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.02.015","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}